AST

AM Best Affirms Credit Ratings and Assigns National Scale Rating to PT Asuransi Samsung Tugu

Retrieved on: 
Wednesday, October 18, 2023
Insurance, Professional Services, NSR, TBK, AM Best, AST, Credit, News, Acquisition, AM, AAA, Information technology, SFM, FSR, ID, Risk management, Marketing, Communication, ALL, Samsung, Reinsurance, Korean

AM Best has affirmed the Financial Strength Rating (FSR) A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of PT Asuransi Samsung Tugu (AST) (Indonesia).

Key Points: 
  • AM Best has affirmed the Financial Strength Rating (FSR) A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of PT Asuransi Samsung Tugu (AST) (Indonesia).
  • Additionally, AM Best has assigned the Indonesia National Scale Rating (NSR) of aaa.ID (Exceptional) to AST.
  • The ratings also recognise the wide range of support provided by AST’s parent, Samsung Fire & Marine Insurance Co., Ltd. (SFM).
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings .

Asia-Pacific Satellite Internet Market Report 2023-2030: Upcoming "Gen 2" Satellite Network Promises Enhanced Speeds and Capacity - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 18, 2023
Technology, Mobile, Wireless, 5G, Carriers and Services, Satellite, Telecommunications, Networks, Internet, Consumer Electronics, Internet of things, Second generation, Musk, PT&T, Optus, GEO, AST, Internet access, Hughes Network Systems, Crucial X8, NBN, Growth, OneWeb, Disaster, AST SpaceMobile, GEOS, PT, KDDI, NTN, Investment, LEO, Spectra, Communication, Television, Communications satellite, Renewable energy, Mobile phone, Retail, Telstra, Starlink, Kuiper

The "Asia-Pacific Satellite Internet Market Report 2023-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Asia-Pacific Satellite Internet Market Report 2023-2030" report has been added to ResearchAndMarkets.com's offering.
  • In terms of revenue, satellite internet operators in the region generated nearly USD 900 million in 2022 following the regional launch of Starlink.
  • However, the growth of the satellite broadband market is closely linked to regulatory challenges and the limited availability of spectrum.
  • An upcoming "Gen 2" network promises enhanced speeds and user capacity.

T2 Biosystems Announces Reverse Stock Split Effective Today

Retrieved on: 
Thursday, October 12, 2023
Transfer, AST, Letter, Common stock, CUSIP, Form, CRG, Security (finance), Auction

The reverse stock split will become effective today, October 12, 2023.

Key Points: 
  • The reverse stock split will become effective today, October 12, 2023.
  • The reverse stock split will not affect the number of authorized shares of the Company’s common stock or the par value of the common stock.
  • The new CUSIP number for the Company’s common stock following the reverse stock split will be 89853L 302.
  • American Stock Transfer & Trust Company, LLC (“AST”), the Company’s transfer agent, will act as the exchange agent for the reverse stock split.

Appalachian Regional Clean Hydrogen (ARCH2) Selected by the Department of Energy (DOE) to Develop Multi-State Clean Hydrogen Hub

Retrieved on: 
Friday, October 13, 2023
Science, Other Science, Oil, Gas, Sustainability, Environment, Alternative Energy, Energy, Green Technology, Hydrogen, CNX, Partnership, Air Liquide, AST, Consultant, Government, Chemours, Hub, U.S. Department of Energy, Office of Inspector General, National Energy Technology Laboratory, Transport, NETL, Carbon, Natural gas, Plug Power, Primary energy, Appalachian Mountains, D, Workforce, Project management office, DOE, TC Energy, Resource, OCED, Dominion Energy, EQT, National Program Office, U.S. Department of Defense Strategy for Operating in Cyberspace, Renewable energy

Battelle announced today that following a highly competitive evaluation process, the Appalachian Regional Clean Hydrogen Hub (ARCH2) consortium was selected by the Department of Energy (DOE) Office of Clean Energy Demonstrations (OCED) to enter the award negotiation phase to establish a clean hydrogen hub (H2Hub) in Appalachia.

Key Points: 
  • Battelle announced today that following a highly competitive evaluation process, the Appalachian Regional Clean Hydrogen Hub (ARCH2) consortium was selected by the Department of Energy (DOE) Office of Clean Energy Demonstrations (OCED) to enter the award negotiation phase to establish a clean hydrogen hub (H2Hub) in Appalachia.
  • The H2Hubs will kickstart a national network of clean hydrogen producers, consumers, and connective infrastructure while supporting the production, storage, delivery, and end-use of clean hydrogen.
  • Concentrated in Appalachian counties across West Virginia, Ohio, Kentucky, and Pennsylvania, ARCH2 will leverage diverse regional resources to build a safe, sustainable clean hydrogen hub that can scale and integrate into a national clean H2 network.
  • “I am so honored to announce that today the U.S. Department of Energy has selected the Appalachian Regional Clean Hydrogen Hub for up to $925 million in federal support under the Bipartisan Infrastructure Law,” said Senator Joe Manchin (D – WV).

Allegheny Science & Technology Partners with ARCH2 Regional Clean Hydrogen Hub

Retrieved on: 
Monday, October 16, 2023
Hydrogen, Multimedia, SME, AST, Consultant, Sustainability, ESG, Human, United States Department of Energy, Carbon, OH, Appalachian Mountains, PMO, Workforce, Project management office, DOE, Information technology, Community benefits agreement, Science, OCED, Renewable energy, Online shopping

BRIDGEPORT, W.Va., Oct. 16, 2023 /PRNewswire/ -- Allegheny Science & Technology (AST), a WV-based company specializing in energy, information technology, ESG, and advanced manufacturing solutions, was notified Friday that the Department of Energy's (DOE) Office of Clean Energy Demonstrations (OCED) has selected the Appalachian Regional Clean Hydrogen Hub (ARCH2) consortium to establish a clean hydrogen hub in the Appalachian region.

Key Points: 
  • BRIDGEPORT, W.Va., Oct. 16, 2023 /PRNewswire/ -- Allegheny Science & Technology (AST), a WV-based company specializing in energy, information technology, ESG, and advanced manufacturing solutions, was notified Friday that the Department of Energy's (DOE) Office of Clean Energy Demonstrations (OCED) has selected the Appalachian Regional Clean Hydrogen Hub (ARCH2) consortium to establish a clean hydrogen hub in the Appalachian region.
  • The ARCH2 project team consists of private companies and energy technology stakeholders across the Appalachian region encompassing the states of WV, KY, OH and PA whose operations span the hydrogen value chain.
  • "Clean energy – and a clean planet Earth – is vital to us all," said Arria Hines, CEO of AST.
  • Clean hydrogen offers opportunities to decarbonize existing energy sources along with the flexibility and scalability to meet growing national energy demand," she noted.

Asia-Pacific Satellite Internet Market Analysis Report 2023-2030: Starlink's Rapid Expansion Raises Geopolitical and Regulatory Concerns

Retrieved on: 
Friday, October 13, 2023
Second generation, Investment, KDDI, Disaster, PT, AST, AST SpaceMobile, Spectra, Crucial X8, GEOS, Communication, PT&T, LEO, NTN, Growth, Optus, Hughes Network Systems, GEO, Musk, NBN, OneWeb, Internet of things, Internet access, Satellite, Communications satellite, Renewable energy, Mobile phone, Retail, Starlink, Kuiper, Telstra

DUBLIN, Oct. 13, 2023 /PRNewswire/ -- The "Asia-Pacific Satellite Internet Market Report 2023-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Oct. 13, 2023 /PRNewswire/ -- The "Asia-Pacific Satellite Internet Market Report 2023-2030" report has been added to ResearchAndMarkets.com's offering.
  • The Asia-Pacific region has experienced rapid growth in satellite broadband connectivity due to its unique geographical challenges, increasing demand for internet access, and technological advancements.
  • In terms of revenue, satellite internet operators in the region generated nearly USD 900 million in 2022 following the regional launch of Starlink.
  • However, the growth of the satellite broadband market is closely linked to regulatory challenges and the limited availability of spectrum.

TRC Companies, Inc. selected to participate in Department of Energy (DOE) Multi-State Clean Hydrogen Hub

Retrieved on: 
Friday, October 13, 2023
Hydrogen, AST, Battelle, Carbon, Primary energy, Appalachian Mountains, TRC, Workforce, Environment, Growth, DOE, Project management office, OCED, Oil, Coal

WINDSOR, Conn., Oct. 13, 2023 /PRNewswire-PRWeb/ -- TRC Companies, Inc. (TRC) has been selected to participate in the Department of Energy (DOE) multi-state clean hydrogen hub. TRC is part of the Appalachian Regional Clean Hydrogen Hub (ARCH2) consortium that was chosen by the DOE Office of Clean Energy Demonstrations (OCED) to negotiate for award to establish a clean hydrogen hub in Appalachia.

Key Points: 
  • TRC Companies, Inc. (TRC) has been selected to participate in the Department of Energy (DOE) multi-state clean hydrogen hub.
  • TRC is part of the Appalachian Regional Clean Hydrogen Hub (ARCH2) consortium that was chosen by the DOE Office of Clean Energy Demonstrations (OCED) to negotiate for award to establish a clean hydrogen hub in Appalachia.
  • WINDSOR, Conn., Oct. 13, 2023 /PRNewswire-PRWeb/ -- TRC Companies, Inc. (TRC) has been selected to participate in the Department of Energy (DOE) multi-state clean hydrogen hub.
  • TRC is part of the Appalachian Regional Clean Hydrogen Hub (ARCH2) consortium that was chosen by the DOE Office of Clean Energy Demonstrations (OCED) to negotiate for award to establish a clean hydrogen hub in Appalachia.

Nuvalent Reports Preliminary Phase 1 Clinical Data from ALKOVE-1 Trial that Support Best-In-Class Potential of NVL-655 for Patients with ALK-Positive NSCLC

Retrieved on: 
Friday, October 13, 2023
Index, Incidence, HIV disease progression rates, Physician, Neoplasm, ROS1, AST, NSCLC, Brain, ORR, Toxic leukoencephalopathy, Caregiver, MTD, PK, Toxicity, Safety, Mutation, Half-life, Cancer, Nausea, FDA, RECIST, Harvard Medical School, Clinical trial, Trae Elston, History, Patient, EDT, Assistant, ANE, ALT, CNS, ALK, TRK, TKI, Medical imaging, Pharmaceutical industry, Vaccine, Nursing

CAMBRIDGE, Mass., Oct. 13, 2023 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced updated preliminary data from the Phase 1 dose-escalation portion of its ongoing ALKOVE-1 Phase 1/2 clinical trial of NVL-655 for patients with advanced ALK-positive non-small cell lung cancer (NSCLC) and other solid tumors. These data will be presented today at the 35th AACR-NCI-EORTC (ANE) Symposium in Boston, Massachusetts.

Key Points: 
  • Preliminary activity data as of the cut-off date were available from 51 heavily pre-treated response-evaluable NSCLC patients.
  • In the subset of 41 patients treated at dose levels of 50 mg QD or higher, the ORR was 44% (18/41).
  • The Phase 2 cohorts are intended to support potential registration in patients with ALK-positive NSCLC who are both lorlatinib-naïve and lorlatinib-treated.
  • In addition to the planned Phase 2 cohorts, Nuvalent intends to use these preliminary data in patients with heavily pre-treated ALK-positive NSCLC to guide discussions with physicians that will inform development strategies in TKI-naïve ALK-positive NSCLC.

Day Zero Diagnostics to Present AI-Based Antimicrobial Susceptibility Testing Predictive Models at ID Week

Retrieved on: 
Tuesday, October 10, 2023
ID, DZD, AST, HAI, Infection, Infectious Diseases Society of America, WGS, ABC, Computational biology, Television, Vaccine

BOSTON, Oct. 10, 2023 /PRNewswire/ -- Day Zero Diagnostics Inc. (DZD), an infectious disease diagnostics company harnessing the power of whole-genome sequencing and AI to combat the rise of antibiotic-resistant infections, announced today that it has been selected to deliver two presentations at the 2023 ID Week conference. ID Week is the premier annual conference organized by the Infectious Disease Society of America and will take place October 11-15 in Boston.

Key Points: 
  • ID Week is the premier annual conference organized by the Infectious Disease Society of America and will take place October 11-15 in Boston.
  • Dr. Miriam Huntley, Chief Technology Officer, will present Keynome® gAST, Day Zero Diagnostics' AI-based algorithm that uses whole genome sequences to predict the antimicrobial susceptibility (AST) of an infection, and discuss how this novel technology will impact the future diagnostics and treatment of infectious disease.
  • In addition to the scientific talks, Day Zero Diagnostics is launching a new commercial service at ID Week under its Day Zero Lab Services brand.
  • This new service expands Day Zero Lab Services commercial offerings and is a complement to epiXact® HAI – DZD's market-leading CLIA-certified healthcare-associated infection (HAI) outbreak assay.

Freeline Reports Positive Initial Clinical Data from First Cohort of Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease

Retrieved on: 
Wednesday, October 4, 2023
Gaucher's disease, Half-life, First grade, Cell, Bone pain, AAV, Plasma, Patient, White blood cell, ALT, Liver, Enzyme replacement therapy, Therapy, AST, Study, White, Safety, Disease, Pharmaceutical industry, Vaccine, Medical imaging, Glucocerebrosidase

LONDON, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today reported positive initial safety, tolerability and enzyme activity data from the ongoing Phase 1/2 GALILEO-1 trial evaluating FLT201, its adeno-associated virus (AAV) gene therapy candidate, in Gaucher disease. Gaucher disease is a debilitating genetic disorder in which a deficiency of the GCase enzyme leads to a buildup of harmful substrates, causing symptoms including enlarged spleen and liver, low blood counts, bone pain and reduced lung function. In addition to demonstrating a favorable safety and tolerability profile, data from the first two patients in GALILEO-1 show that a single infusion of FLT201 led to several hundred-fold increases in GCase activity in plasma and normalization of GCase activity in leukocytes.

Key Points: 
  • ET
    LONDON, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today reported positive initial safety, tolerability and enzyme activity data from the ongoing Phase 1/2 GALILEO-1 trial evaluating FLT201, its adeno-associated virus (AAV) gene therapy candidate, in Gaucher disease.
  • "These initial clinical data are very compelling,” said Pilar Giraldo, M.D., Ph.D., hematologist at the Spanish Foundation for the Study and Therapy of Gaucher Disease, Quirónsalud Hospital – Zaragoza, and an investigator in the GALILEO-1 trial.
  • “While existing therapies have had a significant impact on the disease, many patients continue to experience symptoms and current therapies come with a heavy lifelong treatment burden.
  • ET today to discuss these initial clinical data for FLT201 in Gaucher disease.